HAVRIX 1440 susp inj (n ser pré) ser pré 1 ml
7680005580023
Pharmacode 1108229
CH-558
J07BC02
08.08.
1 / 3
google
Details
- GTIN
- 7680005580023
- Pharmacode
- 1108229
- Product number
- 0055802
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- Vaccinum adsorbatum: hepatitis-A-virus inactivatus (HM175) 1440 U. corresp. proteina max. 0.4 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.5 mg, aminoacida cum phenylalaninum 166 µg, dinatrii phosphas, kalii dihydrogenophosphas, natrii chloridum, kalii chloridum, polysorbatum 20, aqua ad iniectabile, ad suspensionem pro 1 ml corresp. natrium max. 3.6 mg et kalium max. 0.5 mg, residui: neomycini sulfas.
Articles (1)
Havrix 1440, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
hepatitis-A-virus inactivatus (HM175)
|
1440.0 U | Substance | Wirkstoff (Principe actif) |
|
proteina
|
- | Substance | WIZUS |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
aluminium
|
0.5 MG | Substance | HNIDK |
|
aminoacida
|
- | Substance | HNIDK |
|
phenylalaninum
|
166.0 UG | Substance | HBESI |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
kalium
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 51.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2008
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 558
- Drug name
- Havrix 1440, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/09/1993
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HAVRIX 1440 susp inj (n ser pré) ser pré 1 ml
- Description (DE)
- HAVRIX 1440 Inj Susp (n Fertspr) Fertspr 1 ml
- Market launch
- 03/09/1993
- Narcotic (BTM)
- No
Application methods
IMU